Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 8/29/2024CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...
  • 8/28/2024Mundipharma Fails to Sell China Unit for the Second Time Amidst High V...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Develop...
  • 8/27/2024Duality Biothera Seeks Hong Kong IPO to Advance BioNTech-Collaborated ...
  • 8/27/2024Hengrui Secures Chinese Approval of IL-17A mAb, Vunakizumab
  • 8/27/2024BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
  • 8/27/2024Sanofi Suspends Supply and Sale of Flu Vaccine in China
  • 8/27/2024Legend Biotech Wins Chinese Approval of CAR-T Carvykti (Cilta-cel)
  • 8/27/2024NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
  • 8/26/2024Over 70% of Village Clinics Now Covered by the BMI System
  • 8/26/2024China Escalates Crackdown on Medical Insurance Frauds
  • 8/26/2024Recent Study Reveals Alarming Rise in Obesity-Related Cancers in China
  • 8/26/2024Chinese and U.S. Scientists Unveil New AI Model to Advance Drug Disco...
  • 8/26/2024Chinese Pharma Cos Set Sights on Dominating Therapeutic Cancer Vaccine...
  • 8/26/2024China Issues the Notice on Facilitating the BMI for Urban and Rural Re...
  • 8/26/2024CDE Solicits Public Comments on the Q&As on Clinical Guidelines for Dr...
  • 8/26/2024CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
  • 8/26/2024CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
  • 8/26/2024CDE Solicits Public Comments on the Guidelines for Writing Clinical-Re...
  • 8/26/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 8/26/2024BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/S...
  • 8/26/2024Akeso Biopharma Registers New Phase III Clinical Trial for AK112 in Ch...
  • 8/26/2024UCB Sells Chinese Neurology and Allergy Business for $680M
  • 8/23/2024Recent Executive Moves
  • 8/23/2024China Approves Innovent's Dupert for Advanced Lung Cancer Treatment
  • 8/22/2024China Further Opens Telecom, Education, and Healthcare Sectors to Fore...
  • 8/22/2024Bridge Biothera Teams Up with HitGen to Develop Novel Cancer Drug
  • Page:46/52 Total number of articles:1550: [First][<<] [44] [45] [46] [47] [48] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group